Why the study?
Do pharmacist-led interventions improve hypertension control and cardiovascular disease risk management in primary care?
Do pharmacist-led interventions improve hypertension control and cardiovascular disease risk management in primary care?
Integrating pharmacists into primary care teams is advocated to improve hypertension control and cardiovascular disease risk management.
Supports pharmacist integration in primary care hypertension management; leaves open need for RCTs to confirm CV risk reduction.
HEARTS Pharmacy, a project within the HEARTS in the Americas Initiative, provides a framework to integrate pharmacists into primary health care. Pharmacists are highly respected in health care but face challenges, such as limited scope of practice, regulatory barriers, and insufficient recognition, compounded by social norms that hinder their full potential. This paper presents compelling evidence that pharmacist-led interventions improve blood pressure control, lower cardiovascular risk, and reduce health care costs. It underscores the role of national pharmacy systems in ensuring access to high-quality medications. HEARTS Pharmacy emphasizes the role pharmacists play in team-based care, highlighting their expertise in medication management, patient education, and adherence. This paper advocates policy changes that empower pharmacists with greater responsibility, enabling them to play an active role in patient care. It also recommends actions to fully integrate pharmacists into care teams, positioning them as key players in hypertension control and cardio-vascular disease risk management within primary health care.
No takes yet. Share an insight, caveat, or question.
Ridley et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: